AQP4+ NMOSD, MDA5+ Clinically Amyopathic Dermatomyositis and sHLH in a Pediatric Patient: A Case Report and Literature Review. [PDF]
Zhang Z +5 more
europepmc +1 more source
Outcomes of Immune Check Point Inhibitor Use in US Veterans With Pre-Existing Idiopathic Inflammatory Myopathies: Case Series and Literature Review. [PDF]
Krutko D +8 more
europepmc +1 more source
Extensive Pneumomediastinum, Pneumopericardium, and Subcutaneous Emphysema Complicating Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Positive Dermatomyositis-Associated Fibrosing Interstitial Lung Disease: A CT-Based Case Report. [PDF]
Choukri EM +8 more
europepmc +1 more source
Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report. [PDF]
Kukida Y, Inoue H.
europepmc +1 more source
Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers. [PDF]
Lyu X +5 more
europepmc +1 more source
Assessment of CDASI scoring by a multimodal large language model: a comparative study with expert assessors. [PDF]
Fornaro M +5 more
europepmc +1 more source
Multicentric Reticulohistiocytosis-Like Clinicopathologic Features Preceding Anti-MDA5 Antibody-Associated Dermatomyositis With Interstitial Lung Disease. [PDF]
Watabe D, Nakaya I, Amano H.
europepmc +1 more source
Correction to: OA20 A case of rapidly progressive interstitial lung disease in anti-Ro52 positive amyopathic dermatomyositis. [PDF]
europepmc +1 more source

